Phase III registrational trial of pridopidine in patients with Huntington's disease.
Phase of Trial: Phase III
Latest Information Update: 27 Sep 2011
At a glance
- Drugs Pridopidine (Primary)
- Indications Huntington's disease
- Focus Registrational; Therapeutic Use
- Acronyms Prime-HD
- 27 Sep 2011 Planned number of patients changed to 630, according to a NeuroSearch media release.
- 27 Sep 2011 Planned initiation date changed to 1 Jun 2011, according to a NeuroSearch media release.
- 26 May 2011 New trial record